Related Experiment Videos
Alzheimer's disease: Abeta, tau and synaptic dysfunction.
Frank M LaFerla1, Salvatore Oddo
1Department of Neurobiology and Behavior, University of California, Irvine, CA 92697-4545, USA.
Trends in Molecular Medicine
|April 13, 2005
Summary
Alzheimer's disease research advances using transgenic mice that develop both amyloid plaques and neurofibrillary tangles. These models offer new insights into disease mechanisms and therapeutic development for Alzheimer's disease.
Area of Science:
- Neuroscience
- Pathology
- Genetics
Background:
- Alzheimer's disease (AD) is a progressive neurodegenerative disorder.
- Key pathological hallmarks include extracellular amyloid plaques and neurofibrillary tangles.
- Reproducing both hallmarks in animal models has been a significant challenge.
Purpose of the Study:
- To investigate the role of amyloid plaques and neurofibrillary tangles in Alzheimer's pathogenesis.
- To leverage advances in transgenic mouse models that recapitulate AD neuropathology.
- To gain novel insights into the degenerative process and therapeutic strategies.
Main Methods:
- Development and utilization of transgenic mice exhibiting both amyloid plaques and neurofibrillary tangles.
- In vivo studies to observe the impact of these lesions on brain function.
- Analysis of synaptic activity and plasticity in affected mouse models.
Main Results:
- Recent advances enable the successful recapitulation of both plaques and tangles in mouse brains.
- These models provide novel insights into the degenerative process of Alzheimer's disease.
- The impact of these lesions on synaptic activity and plasticity is being elucidated.
Conclusions:
- Transgenic mice harboring both neuropathological lesions are crucial for understanding AD.
- These models facilitate the study of the relationship between protein aggregates.
- They provide a vital in vivo system for developing and evaluating potential therapies for Alzheimer's disease.